These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34188467)

  • 1. Prevalence and Associated Factors of Suboptimal Daily Peak Inspiratory Flow and Technique Misuse of Dry Powder Inhalers in Outpatients with Stable Chronic Airway Diseases.
    Ding N; Zhang W; Wang Z; Bai C; He Q; Dong Y; Feng X; Zhang J; Gao S
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1913-1924. PubMed ID: 34188467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.
    Ghosh S; Pleasants RA; Ohar JA; Donohue JF; Drummond MB
    Int J Chron Obstruct Pulmon Dis; 2019; 14():585-595. PubMed ID: 30880948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Evaluation of Exacerbations Associated with Suboptimal Peak Inspiratory Flow Among Stable Outpatients with COPD.
    Mahler DA; Niu X; Deering KL; Dembek C
    Int J Chron Obstruct Pulmon Dis; 2022; 17():559-568. PubMed ID: 35313719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD.
    Jõgi R; Mattila L; Vahteristo M; Takala A; Lähelmä S; Vartiainen VA; Lindqvist A
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1193-1201. PubMed ID: 33958863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
    Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
    BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.
    Price DB; Yang S; Ming SWY; Hardjojo A; Cabrera C; Papaioannou AI; Loukides S; Kritikos V; Bosnic-Anticevich SZ; Carter V; Dorinsky PM
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3937-3946. PubMed ID: 30587952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The variability of peak inspiratory flow (PIF) on valves imitating dry powder inhalers resistance during asthma and COPD exacerbations].
    Grabowski M; Barg W; Chmielowicz B; Kopeć A; Panaszek B
    Pneumonol Alergol Pol; 2007; 75(4):324-30. PubMed ID: 18080981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma.
    Hua JL; Ye XF; Du CL; Xie N; Zhang JQ; Li M; Zhang J
    BMC Pulm Med; 2021 Sep; 21(1):302. PubMed ID: 34560863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs).
    Terzano C; Oriolo F
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea.
    Moon JY; Kim SH; Kim Y; Lee H; Rhee CK; Ra SW; Lee CY; Park JH; Park YB; Yoo KH
    Pulm Pharmacol Ther; 2024 Jun; 85():102298. PubMed ID: 38604404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Prevalence of Suboptimal Peak Inspiratory Flow in Hospitalized Patients With COPD: A Real-world Study.
    Mahler DA; Demirel S; Hollander R; Gopalan G; Shaikh A; Mahle CD; Elder J; Morrison C
    Chronic Obstr Pulm Dis; 2022 Jul; 9(3):427-438. PubMed ID: 35788259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease.
    Ohar JA; Ferguson GT; Mahler DA; Drummond MB; Dhand R; Pleasants RA; Anzueto A; Halpin DMG; Price DB; Drescher GS; Hoy HM; Haughney J; Hess MW; Usmani OS
    Int J Chron Obstruct Pulmon Dis; 2022; 17():79-92. PubMed ID: 35023914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients.
    Harb HS; Laz NI; Rabea H; Abdelrahim MEA
    Eur J Pharm Sci; 2020 Apr; 147():105298. PubMed ID: 32151707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inspiratory flow rates at different levels of resistance in elderly COPD patients.
    Janssens W; VandenBrande P; Hardeman E; De Langhe E; Philps T; Troosters T; Decramer M
    Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of Suboptimal Peak Inspiratory Flow Rates among Patients with Chronic Obstructive Pulmonary Disease in Southwest, Nigeria.
    Arawomo AO; Erhabor GE; Tanimowo MO; Awopeju OF; Adewole OO; Adeniyi BO; Afolabi BA; Ekundayo MW
    West Afr J Med; 2023 May; 40(5):553-561. PubMed ID: 37247343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].
    Zhang QL; Zheng JP; Pan WH; He H; Chen GL; An JY; Yuan LF; Luo DF
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):98-103. PubMed ID: 19099680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction.
    Broeders ME; Molema J; Hop WC; Folgering HT
    J Aerosol Med; 2003; 16(2):131-41. PubMed ID: 12823907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study.
    Mahler DA; Watz H; Emerson-Stadler R; Ritz J; Gardev A; Shaikh A; Drummond MB
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1729-1740. PubMed ID: 37599896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers.
    Barnes CN; Mahler DA; Ohar JA; Lombardi DA; Crater GD
    Chest; 2020 Oct; 158(4):1413-1419. PubMed ID: 32343967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.